Luvo Health review
Everything is priced per four weeks and per week at once, with twelve, twenty-four and fifty-two week blocks published beside it.
The verdict
Luvo Health publishes $249 per four weeks for compounded semaglutide by injection, read August 2026, and states the same figure as $62 a week alongside it. Three longer commitments are published in full: $657 for twelve weeks, $1,194 for twenty-four and $2,327 for fifty-two, each cutting the weekly rate a little further.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Injection
- From $271/mo
- Oral
- From $303/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Luvo Health sells both molecules, with semaglutide available as an injection or an oral and tirzepatide by injection. Every line carries four figures — a four-week price and three block prices — which means a reader can see the entire commitment ladder on one screen rather than discovering it at checkout.
Who writes the prescription, and what do they see?
A prescription precedes dispensing and the pages concentrate on terms rather than on the clinician behind them. The intake is not documented, so what a prescriber reviews before writing is not something a reader can establish here — a gap that sits oddly beside pricing this thoroughly disclosed.
The four-week interval is the thing to register before comparing anything. A year at Luvo is thirteen four-week periods rather than twelve months, and the fifty-two-week block price is where that becomes visible: $2,327 against what thirteen separate four-week charges at $249 would cost. Publishing the annual block is what lets a reader do that arithmetic at all.
What happens when the dose goes up?
Luvo states its rates hold at every dose. Combined with the published block prices, that makes a full-year calculation genuinely possible here. The two unknowns that usually defeat the exercise, dose escalation and term pricing, are both addressed on the page.
What the price includes
The weekly framing is unusually honest here because Luvo gives both numbers rather than only the small one. Semaglutide runs $249 per four weeks or $62 a week; the oral is $279 and $70; tirzepatide is $339 and $85. Each longer block lowers the weekly rate, so the ladder rewards commitment in a visible, checkable way rather than an advertised one.
What it claims, and what it cites
Every line is compounded, which means none has been through the FDA review an approved product completes before dispensing. The oral semaglutide carries the highest four-week figure of the three lines, which runs against the usual pattern where a tablet undercuts an injection.
Where it holds up, and where it does not
- Strength: Four commitment lengths published on each line
- Strength: Both the weekly and four-week figure given
- Strength: Rate stated to hold at every dose
- Strength: A full year can actually be calculated
- Limitation: Four-week billing means thirteen periods
- Limitation: The oral costs more than the injection
- Limitation: No milligram dose is published
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Luvo Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants to price a full year before starting and can read a four-week interval correctly.
- Wrong for
- A reader comparing against monthly sellers without adjusting for the shorter period.
How Luvo Health compares
| Seller | Who it suits | Go |
|---|---|---|
| A reader who expects to stay past the first quarter and wants provider check-ins inside the price rather than billed against each visit. | See Pallas Health → | |
| A reader who can pay a year at once, or finance it, and wants the per-month figure to stop moving as the dose rises. | See Trimi Health → | |
| Lean Meds | A reader deciding between paying month to month and committing a year up front, because both rungs are published side by side. | See Lean Meds → |
More GLP-1 telehealth sellers reviews: PlushCarePreventiveMDRevel HealthSesame CareWholesome ClinicZera Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $249 a monthly price?
- No. It covers four weeks, so a year is thirteen such periods rather than twelve. Luvo publishes a fifty-two-week block at $2,327, which is the figure to compare against an annual total elsewhere.
- Do the longer blocks actually save money?
- Yes, and visibly: each block lowers the stated weekly rate, from $62 on the four-week price down across the twelve, twenty-four and fifty-two week commitments.
- Why is the tablet more expensive?
- That is how Luvo prices it, at $279 per four weeks against $249 for the injection. The pages offer no reason, and the direction runs against most of the category.
- Is Luvo Health expensive compared with other GLP-1 telehealth sellers?
- Luvo Health publishes a starting figure of $271/mo. Across the 83 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Luvo Health above the median. The other 5 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.